DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Valerian is an investigational drug.
There have been 9 clinical trials for Valerian. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2001.
The most common disease conditions in clinical trials are Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, and Parkinson Disease. The leading clinical trial sponsors are Pascoe Pharmazeutische Praeparate GmbH, Prof. Huss, and Boehringer Ingelheim.
Recent Clinical Trials for Valerian
|Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.||Universidad Autonoma de San Luis Potosí||Phase 3|
|Therapeutic Effect of an Herbal Medicine on Anxiety||Millet Roux||Phase 3|
|Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety||Marjan Industria e Comercio ltda||Phase 3|